Breaking News

Vertex Pharmaceuticals Inc (VRTX)

Symbol	Exchange	Currency
VRTX	NASDAQ	USD	Real-time
VRTX	Mexico	MXN	Delayed
1VRTX	Milan	EUR	Real-time
VRTX	TradeGate	EUR	Delayed
VRTX	Frankfurt	EUR	Delayed
VRTX34	B3	BRL	Delayed
VRTX	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

8,816.46 0.00 0.00%

09/07 - Closed. Currency in MXN

Type: Equity

Market: Mexico

ISIN: US92532F1003

S/N: 92532F100

Volume: 0
Bid/Ask: 8,820.00 / 9,160.79
Day's Range: 8,816.46 - 8,816.46

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Vertex Pharmaceuticals Inc Company Profile

Get an in-depth profile of Vertex Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

6100

Equity Type

ORD

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of sickle cell disease and transfusion-dependent beta thalassemia; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease which is in single Phase 2; VX-880 and VX-264, treatment for Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Contact Information

Address 50 Northern Avenue
Boston, 02210
United States

Phone 617 341 6100

Fax -

Web www.vrtx.com

Top Executives

Name	Age	Since	Title
Sangeeta N. Bhatia	56	2015	Independent Director
Alan M. Garber	69	2017	Independent Director
Michel Lagarde	50	2023	Independent Director
Lloyd A. Carney	63	2019	Independent Director
Bruce I. Sachs	65	1998	Lead Independent Director
Nancy A. Thornberry	68	2023	Independent Director
Diana Lynne McKenzie	60	2020	Independent Director
Suketu P. Upadhyay	56	2022	Independent Director
Jennifer Schneider	48	2024	Independent Director
Jeffrey Marc Leiden	69	2009	Executive Chairman
Reshma Kewalramani	52	2017	CEO, President & Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

VRTX Comments

Write your thoughts about Vertex Pharmaceuticals Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Maria Kenny May 05, 2025 5:11PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

don't know how this has gotten so far at such a valuation. So much air left in the S&P

0 2

Report

gururaj anand1984 Jan 06, 2025 10:10AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

(SGMO) Sangamo Therapeutics under vaccine research for HMPV Virus. Expected share price to hit 100$ as trading now around 2$. big jump and big news soon for china expected from this company. multiply your asset by investing in this stock. just try minimum 100$ and see the result in one month.

0 4

Report

Rakesh Patel Jul 19, 2023 12:34PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

i observe this stock last 1 year... similarly i seen it's website.... product, what is going on mentioned in website.. story, company growth etc.. so you shall refer same as compare to stock price. If growth story is excellent then stock will be good bounce back after 1,2,3, ..years...

5 2

Report

Anisul Islam Jul 19, 2023 12:34PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Vikas number 01781054242

0 0

Report

Petet Larkar Apr 27, 2023 2:36PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

great stock still good price ATH

0 0

Report

Vijay shepherd presented movie Apr 27, 2023 2:36PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

ghf

0 0

Report

Cardarius Lockett Dec 08, 2022 2:45PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Thank for the Vibe and offer VRTX! I like to earn $319.92 for I can invest in to stock really bad

0 0

Report

kay brown Dec 08, 2022 2:45PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

wow

0 0

Report

anoldguy Oct 24, 2022 8:19AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Kathy Wood is selling, time to load up long!

3 0

Report

RF RF Feb 04, 2022 10:20AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Thanks for the ride VRTX!

2 0

Report

Дмитрий Счастливый Feb 02, 2022 11:18AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

New moderna/ more shorts plz =))) --->295

2 2

Report

Utónév vezetéknév Jan 06, 2022 7:58AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Keeps this stock, rotation from tech growth to value stock is coming this year, I expect VRTX will benefit from this.

8 1

Report

Nuno Santos Jan 06, 2022 7:58AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

What a priceless tought. Safe money here in this actual cenario...

2 0

Report

Vanessa Melchers Dec 22, 2021 4:16PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

this is a most unexpected though long awaited bump. glad i held

2 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="209107838">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="209107838" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="209107838" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="209107838">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="201777450">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="201777450" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="201777450" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="201777450">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	44,330.0	-155.1	-0.35%
US 500	6,296.6	-0.9	-0.01%
Dow Jones	44,342.19	-142.30	-0.32%
S&P 500	6,296.79	-0.57	-0.01%
Nasdaq	20,895.66	+10.01	+0.05%
S&P 500 VIX	16.41	-0.11	-0.67%
Dollar Index	98.200	-0.250	-0.25%

Crude Oil WTI	67.34	-0.20	-0.30%
Brent Oil	69.28	-0.24	-0.35%
Natural Gas	3.565	+0.023	+0.65%
Gold	3,358.30	+13.00	+0.39%
Silver	38.464	+0.161	+0.42%
Copper	5.6045	+0.0920	+1.67%
US Soybeans	1,021.00	+9.00	+0.89%

U.S. 10Y	4.431	-0.032	-0.72%
U.S. 30Y	4.999	-0.015	-0.30%
U.S. 5Y	3.961	-0.045	-1.12%
U.S. 3M	4.341	-0.004	-0.09%
US 10Y T-Note	110.78	+0.27	+0.24%
Euro Bund	129.55	-0.28	-0.22%
10-2 Yield Spread	31.32	+4.15	+15.27%

Apple	211.18	+1.16	+0.55%
NVIDIA	172.41	-0.59	-0.34%
Alphabet A	185.06	+1.48	+0.81%
Tesla	329.65	+10.24	+3.21%
Amazon.com	226.13	+2.25	+1.01%
Netflix	1,209.24	-64.93	-5.10%
Meta Platforms	704.28	+2.87	+0.41%

Recent Quotes

	Name	Price	Chg.	Chg. %
	VRTX	8,816.46	0.00	0.00%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	172.41	-0.34%	146.46M
TSLA	329.65	+3.21%	94.25M
AAPL	211.18	+0.55%	48.97M
CRCL	223.78	-4.81%	42.88M
COIN	419.78	+2.20%	28.06M
MSFT	510.05	-0.32%	21.21M
NFLX	1,209.24	-5.10%	10.69M

Name	Last	Chg. %	Vol.
IVZ	19.92	+15.28%	35.67M
RF	26.01	+6.12%	23.43M
VST	193.01	+6.05%	6.42M
DELL	131.24	+5.94%	11.03M
CEG	321.42	+4.33%	3.53M
MRVL	74.65	+3.67%	16.91M
TSLA	329.65	+3.21%	94.25M

Name	Last	Chg. %	Vol.
MOH	182.98	-10.41%	3.59M
ELV	277.09	-8.38%	8.39M
MSTR	423.22	-6.23%	19.11M
NFLX	1,209.24	-5.10%	10.69M
WST	210.89	-4.83%	1.47M
ANSS	374.30	-4.69%	18.89M
VTRS	8.88	-4.21%	9.92M

Webinars

From Beginner to Pro: Navigating Your InvestingPro Subscription Wednesday, July 30, 2025 | 10:00AM EDT